UK markets open in 6 hours 47 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.78-0.14 (-0.59%)
At close: 04:00PM EDT
23.78 0.00 (0.00%)
After hours: 05:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.96B
Enterprise value 2.86B
Trailing P/E 478.56
Forward P/E 111.11
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.10
Price/book (mrq)18.48
Enterprise value/revenue 15.75
Enterprise value/EBITDA -10.66

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-28.77%
S&P500 52-week change 323.06%
52-week high 342.48
52-week low 320.67
50-day moving average 328.66
200-day moving average 329.25

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 3931.16k
Shares outstanding 5123.9M
Implied shares outstanding 6123.9M
Float 8118.95M
% held by insiders 14.49%
% held by institutions 166.86%
Shares short (28 Mar 2024) 48.87M
Short ratio (28 Mar 2024) 45.77
Short % of float (28 Mar 2024) 48.40%
Short % of shares outstanding (28 Mar 2024) 47.16%
Shares short (prior month 29 Feb 2024) 48.84M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 317 Nov 2011

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -163.32%
Operating margin (ttm)-3,845.25%

Management effectiveness

Return on assets (ttm)-24.66%
Return on equity (ttm)-106.24%

Income statement

Revenue (ttm)181.74M
Revenue per share (ttm)1.70
Quarterly revenue growth (yoy)-94.30%
Gross profit (ttm)N/A
EBITDA -285.35M
Net income avi to common (ttm)-296.81M
Diluted EPS (ttm)-2.77
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)213.38M
Total cash per share (mrq)1.72
Total debt (mrq)392.27M
Total debt/equity (mrq)225.81%
Current ratio (mrq)3.73
Book value per share (mrq)1.49

Cash flow statement

Operating cash flow (ttm)-196.21M
Levered free cash flow (ttm)-317.24M